Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.

NCT00871741 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00871741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00871741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Terminated
Start date
April 1, 2009
Completion date
June 25, 2009
Enrollment
16 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acellular pertussis, diphtheria, haemophilus influenzae type b, hepatitis b, neisseria meningitidis, poliomyelitis, tetanus